CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt ; volume:13 ; number:2 ; day:18 ; month:5 ; year:2023 ; pages:374-383 ; date:6.2023
Journal of epidemiology and global health ; 13, Heft 2 (18.5.2023), 374-383, 6.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s44197-023-00113-4
- URN
-
urn:nbn:de:101:1-2023092112592015217503
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shawky, Ahmed
- Sabit, Hussein
- Nazih, Mahmoud
- Baraka, Khalid
- El-Zawahry, Mokhtar
- SpringerLink (Online service)
Ähnliche Objekte (12)
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
Comparision Between Clopidogrel and Prasugrel On hs-CRP Levels Post Percutaneous Intervention
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial
METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
Comparision Between Clopidogrel and Prasugrel On hs-CRP Levels Post Percutaneous Intervention
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial
METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
Comparision Between Clopidogrel and Prasugrel On hs-CRP Levels Post Percutaneous Intervention
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial
METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events